Notice – MANTICORE LABS OÜ (o/a COINFIELD) AND MANTICORE LABS INC., File No. 2023-24
TORONTO, Nov. 6, 2023 /CNW/ – The Tribunal issued an Order in the above-named matter. A copy of the Order dated November 6, 2023 is available at capitalmarketstribunal.ca Registrar, Governance & Tribunal Secretariat Ontario Securities Commission SOURCE Ontario Securities Commission
Roundhill Announces Name and Ticker Symbol Change for Roundhill BIG Tech ETF
NEW YORK, Nov. 6, 2023 /PRNewswire/ — Roundhill Investments (“Roundhill”), a leading provider of innovative financial products, announced a name and ticker symbol change for the Roundhill BIG Tech ETF (NASDAQ: BIGT), updating the fund’s name and ticker to reflect its new focu
Blue Cross and Blue Shield of Texas’ Special Beginnings® initiative to fund additional CenteringPregnancy sites statewide
Collaboration will support 20 more locations with the aim to help improve maternal and infant health outcomes in Texas RICHARDSON, Texas, Nov. 6, 2023 /PRNewswire/ — Blue Cross and Blue Shield of Texas (BCBSTX) continues its collaboration with Centering Healthcare Institute (CHI) to add up
Unlocking Neurovascular Innovations: A Deep Dive into Market Trends and Forecasts to 2033
DUBLIN, Nov. 6, 2023 /PRNewswire/ — The “Neurovascular Accessory Devices Market Size by Segments, Share, Regulatory and Reimbursement, Procedures and Forecast to 2033” report has been added to ResearchAndMarkets.com’s offering, shedding light on the expansive neurovascular
A Full Menu of Festive Holiday Flavor
MISSION, Kan., Nov. 6, 2023 /PRNewswire/ — (Family Features) Cooking up a successful holiday gathering calls for everyone’s favorite recipes. From the centerpiece main dish to fresh salads and appetizers, roasted sides and baked sweets, you can take seasonal get-togethers up a notch by
Boehringer Ingelheim achieves major milestone in chronic kidney disease: aldosterone synthase inhibitor on top of empagliflozin delivers promising results in Phase II trial
Phase II results demonstrated significant albuminuria reductions by up to 39.5% vs. placebo when BI 690517, a novel selective aldosterone synthase inhibitor, was given on top of empagliflozin, an SGLT2 inhibitor, suggesting additive efficacy1Potential new treatment builds on Boehringer IngelheimR
U.S. Navy fields RTX’s StormBreaker smart weapon on the F/A-18E/F Super Hornet
F/A-18 first Navy aircraft to carry StormBreaker TUCSON, Ariz., Nov. 6, 2023 /PRNewswire/ — Raytheon, an RTX (NYSE: RTX) business, today announced that the U.S. Navy has fielded the company’s StormBreaker® smart weapon on the F/A-18E/F Super Hornet. The F/A-18 is the first approved U.S.
Reuters Events announces winners of the 14th Responsible Business Awards 2023 in London
LONDON, Nov. 6, 2023 /PRNewswire/ — Reuters Events announced the winners of the 14th Responsible Business Awards at the in-person ceremony in London where over 280 guests from all over the world came together to celebrate sustainable excellence of business. Responsible Business Awards are a wo
Adhesive Tape Market Projected to Surpass US$ 143.5 billion by 2031, with a CAGR of 6.7%, Transparency Market Research
Adhesive tapes are widely used in the packaging industry for sealing boxes and cartons. The ecommerce boom, increased demand for convenience packaging, and the need for secure and tamper evident packaging have led to a higher demand for adhesive tapes. WILMINGTON, Del., Nov. 6, 2023 /PRNewswire/ 
Quad-C Exits Investment in MNX in Sale to UPS
CHARLOTTESVILLE, Va., Nov. 6, 2023 /PRNewswire/ — Quad-C Management, Inc. (“Quad-C”), a leading middle market private equity firm, today announced it has closed the sale of its investment in MNX Global Logistics (“MNX” or the “Company”), a U.S.-based global
